AMSilk to partake in SynBioBeta 2017 to be held next month in San Franciso

AMSilk a leading producer and distributor of increasing volumes of high-quality silk biopolymers are currently used in coatings for medical technology products, in the textile industry and as an ingredient in cosmetic products. They will be participating in this year’s SynBioBeta 2017 to be held next month in San Francisco.

AMSilk CEO Jens Klein has been selected as one of the featured speakers at this year’s event, where he will present the manifold field of applications enabled by AMSilk’s silk biopolymers. The recent advances in synthetic biology have enabled the creation of functional, sustainable and high-performance materials unlike anything they have seen before.

AMSilk’s silk biopolymers are just one example of such materials, and can already be found in a number of trail blasing products around the globe.
Jens Klein said that it is a great pleasure to speak at SynBioBeta and present AMSilk’s products and R&D results on an international level. To bring together so many industry pioneers and innovative companies at one place is remarkable and very inspiring.

SynBioBeta brings together entrepreneurs, investors and industry experts to drive the synthetic biology industry forward. Over 60 industry leaders will discuss the responsible growth of synthetic biology, with featured presentations by molecular biologist and genetics pioneer George Church, the entrepreneur and venture capitalist Vinod Khosla and the medical and biology engineer James Collins, one of the founders of synthetic biology.

SynBioBeta founder and CEO John Cumbers said that they couldn’t be more excited for this year’s conference, which comes at a crucial moment for the synthetic biology industry as a whole. In just the last ten years, the pace of innovation has increased dramatically, and the impact of biotechnology is beginning to be felt in all industries.

Key themes at the SynBioBeta conference this year include biomaterials and consumer goods, cell factories for biopharmaceuticals, big data and artificial intelligence and innovations for ocean sustainability.

Talks and panels will discuss the future of DNA synthesis, why protein is the killer app, investment opportunities throughout the industry and why all companies need to think about a Bio-Strategy in order to compete in the quickly evolving synthetic biology.

AMSilk is an industrial supplier of synthetic silk biopolymers is headquartered in Planegg near Munich, Germany. AMSilk high-performance biopolymers are distributed in the form of Silkbeads (microparticles), Silkgel (hydrogel) or Biosteel fibres. AMSilk high-performance biopolymers have the functional properties of the natural product they are based on.

AMSilk is also the first producer of nature based spider silk fibers in a continous spinning process of Biosteel fiber. AMSilk develops and produces Biosteel fiber relevant to market need and application. Therefore, their spider silk protein is individually designed by their bioengineers.